4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-21-052385
SVP & Chief Commercial Officer sold 6,192 shares at $13.83 ($85,635)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| NORTHCOTT JOHN SVP & Chief Commercial Officer | 2021-08-16 | Sale | −6,192 | $13.83 | $85,635 | 200,915 | D |
| Open-market sales · 6,192 sh · avg $13.83 · $85,635 | |||||||
Loading xslF345X03/doc4.xml…